MEDICALLY REVIEWED

The Role of Dupilumab (Dupixent), an IL-4 Receptor Alpha Antagonist, in Atopic Dermatitis

dupilumab dupixent atopic dermatitis eczema
Among the many new drug approved for the use of atopic dermatitis or eczema, dupilumab (Dupixent) is one of them. Find out about its evidence here.

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: